ORICARE Revenue and Competitors

Quakertown, PA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • ORICARE's estimated annual revenue is currently $2.5M per year.(i)
  • ORICARE's estimated revenue per employee is $251,000

Employee Data

  • ORICARE has 10 Employees.(i)
  • ORICARE grew their employee count by 11% last year.

ORICARE's People

NameTitleEmail/Phone
1
Product Specialist cum Service Manager (India Head) (Oricare Inc, Aeonmed Co. Ltd & Heyer AG)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$73.5M29312%N/AN/A
#2
$7M28-10%N/AN/A
#3
$37.9M15113%N/AN/A
#4
$2.1M17-78%$64.3MN/A
#5
$9.3M37-10%N/AN/A
#6
$56.2M1790%N/AN/A
#7
$38.9M155-1%N/AN/A
#8
$22.1M885%N/AN/A
#9
$22.1M889%N/AN/A
#10
$33.4M13310%N/AN/A
Add Company

What Is ORICARE?

ORICARE Inc. is a US-based manufacturer of OR and ICU medical devices. Since 2009, we have been leading innovators of healthcare solutions. Our product line ranges from Anesthesia Workstations, Critical Care Ventilators, Operating Tables, Surgical Lights, Pendants, Monitors, and much more.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$2.5M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ORICARE News

2022-04-19 - Latest Updated Report of Supply Beam Systems Market 2022 ...

... which Conclude Growth Factors, Analysis, Outlook and Forecast to 2027 | Amcaremed Technology, Sostel, BiHealthcare, Oricare, Pegisdan.

2022-04-19 - Growth Prediction of ICU Supply Beam System Market Covers ...

... Covers in Research Report with Latest Updates and Forecast to 2027 | Amcaremed Technology, Sostel, BiHealthcare, Oricare, Pegisdan.

2022-04-17 - Anesthesia Machine Market Size, Scope And Forecast ...

Hersill, Spacelabs Healthcare, HEYER Medical, Siriusmed, Oricare, Biobase, Fritz Stephan, Mindray, GE Healthcare, Comen, Siare, DRE Medical, Dixion,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M100%N/A
#2
$2M16-6%N/A
#3
$2.2M16-80%N/A
#4
$2.1M21-5%N/A
#5
$1.8M26-21%N/A